Galderma Group
CHF 160.55Change from previous close: −0.16%Absolute change: −CHF 0.25
At a glance
- Revenue growth
- +18.04%
- 2025 vs 2024
- Net income growth
- +165.37%
- 2025 vs 2024
- Net margin
- 11.7%
- 2024: 5.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 13,393 | 12,617 | 12,471 | 12,415 | 12,572 |
| Current assets | 2,437 | 1,843 | 1,616 | 1,507 | 1,517 |
| Cash and equivalents | 780 | 457 | 368 | 234 | 287 |
| Receivables | 1,062 | 905 | 765 | 791 | 732 |
| Inventory | 525 | 403 | 420 | 442 | 347 |
| Net property, plant and equipment | 744 | 577 | 529 | 401 | 342 |
| Goodwill | 5,129 | 5,129 | 5,129 | 5,129 | 5,141 |
| Other intangible assets | 4,639 | 4,829 | 4,923 | 5,100 | 5,282 |
| Long-term investments | 3.0 | 1.0 | 10.0 | 8.8 | 7.3 |
| Current liabilities | 2,055 | 1,528 | 1,571 | 1,961 | 1,857 |
| Accounts payable | 799 | 571 | 557 | 602 | 502 |
| Long-term debt | 2,579 | 2,636 | 4,748 | 5,164 | 5,199 |
| Total debt | 2,754 | 2,760 | 4,909 | — | — |
| Total liabilities | 5,244 | 4,827 | 7,102 | 7,946 | 8,024 |
| Total equity (incl. minority) | 8,149 | 7,790 | 5,369 | 4,469 | 4,548 |
| Retained earnings | 6,347 | 5,676 | -901 | -844 | -745 |